These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 10631109)
1. Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor -/- mice. Sjögren K; Bohlooly-Y M; Olsson B; Coschigano K; Törnell J; Mohan S; Isaksson OG; Baumann G; Kopchick J; Ohlsson C Biochem Biophys Res Commun; 2000 Jan; 267(2):603-8. PubMed ID: 10631109 [TBL] [Abstract][Full Text] [Related]
2. Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis. Venken K; Schuit F; Van Lommel L; Tsukamoto K; Kopchick JJ; Coschigano K; Ohlsson C; Movérare S; Boonen S; Bouillon R; Vanderschueren D J Bone Miner Res; 2005 Dec; 20(12):2138-49. PubMed ID: 16294267 [TBL] [Abstract][Full Text] [Related]
3. A general IGF-I overexpression effectively rescued somatic growth and bone deficiency in mice caused by growth hormone receptor knockout. De Jesus K; Wang X; Liu JL Growth Factors; 2009 Dec; 27(6):438-47. PubMed ID: 19824875 [TBL] [Abstract][Full Text] [Related]
4. Disproportional body growth in female estrogen receptor-alpha-inactivated mice. Vidal O; Lindberg M; Sävendahl L; Lubahn DB; Ritzen EM; Gustafsson JA; Ohlsson C Biochem Biophys Res Commun; 1999 Nov; 265(2):569-71. PubMed ID: 10558910 [TBL] [Abstract][Full Text] [Related]
5. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. Windahl SH; Vidal O; Andersson G; Gustafsson JA; Ohlsson C J Clin Invest; 1999 Oct; 104(7):895-901. PubMed ID: 10510330 [TBL] [Abstract][Full Text] [Related]
6. Bone mineral content and density in the humerus of adult myostatin-deficient mice. Hamrick MW; McPherron AC; Lovejoy CO Calcif Tissue Int; 2002 Jul; 71(1):63-8. PubMed ID: 12060865 [TBL] [Abstract][Full Text] [Related]
7. Effects of liver-derived insulin-like growth factor I on bone metabolism in mice. Sjögren K; Sheng M; Movérare S; Liu JL; Wallenius K; Törnell J; Isaksson O; Jansson JO; Mohan S; Ohlsson C J Bone Miner Res; 2002 Nov; 17(11):1977-87. PubMed ID: 12412805 [TBL] [Abstract][Full Text] [Related]
8. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029 [TBL] [Abstract][Full Text] [Related]
9. Postnatal growth and bone mass in mice with IGF-I haploinsufficiency. He J; Rosen CJ; Adams DJ; Kream BE Bone; 2006 Jun; 38(6):826-35. PubMed ID: 16427371 [TBL] [Abstract][Full Text] [Related]
10. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I. Sjögren K; Jansson JO; Isaksson OG; Ohlsson C Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852 [TBL] [Abstract][Full Text] [Related]
11. Bone geometry and density in the skeleton of pre-pubertal gymnasts and school children. Ward KA; Roberts SA; Adams JE; Mughal MZ Bone; 2005 Jun; 36(6):1012-8. PubMed ID: 15876561 [TBL] [Abstract][Full Text] [Related]
12. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Lupu F; Terwilliger JD; Lee K; Segre GV; Efstratiadis A Dev Biol; 2001 Jan; 229(1):141-62. PubMed ID: 11133160 [TBL] [Abstract][Full Text] [Related]
13. Effects of caloric restriction on insulin pathway gene expression in the skeletal muscle and liver of normal and long-lived GHR-KO mice. Masternak MM; Al-Regaiey KA; Del Rosario Lim MM; Jimenez-Ortega V; Panici JA; Bonkowski MS; Bartke A Exp Gerontol; 2005; 40(8-9):679-84. PubMed ID: 16054319 [TBL] [Abstract][Full Text] [Related]
14. Effects of increased muscle mass on bone in male mice overexpressing IGF-I in skeletal muscles. Banu J; Wang L; Kalu DN Calcif Tissue Int; 2003 Aug; 73(2):196-201. PubMed ID: 14565602 [TBL] [Abstract][Full Text] [Related]
15. Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis. Held MA; Cosme-Blanco W; Difedele LM; Bonkowski EL; Menon RK; Denson LA Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G986-93. PubMed ID: 15604202 [TBL] [Abstract][Full Text] [Related]
16. Bone density, strength, and formation in adult cathepsin K (-/-) mice. Pennypacker B; Shea M; Liu Q; Masarachia P; Saftig P; Rodan S; Rodan G; Kimmel D Bone; 2009 Feb; 44(2):199-207. PubMed ID: 18845279 [TBL] [Abstract][Full Text] [Related]
17. Growth hormone receptor deficiency in mice results in reduced systolic blood pressure and plasma renin, increased aortic eNOS expression, and altered cardiovascular structure and function. Egecioglu E; Andersson IJ; Bollano E; Palsdottir V; Gabrielsson BG; Kopchick JJ; Skott O; Bie P; Isgaard J; Bohlooly-Y M; Bergström G; Wickman A Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1418-25. PubMed ID: 17244725 [TBL] [Abstract][Full Text] [Related]
18. Prenatal programming of skeletal development in the offspring: effects of maternal treatment with beta-hydroxy-beta-methylbutyrate (HMB) on femur properties in pigs at slaughter age. Tatara MR; Sliwa E; Krupski W Bone; 2007 Jun; 40(6):1615-22. PubMed ID: 17433802 [TBL] [Abstract][Full Text] [Related]